---
title: "Digital Therapeutics Industry: Companies"
description: "Digital therapeutics companies deliver clinically tested software that treats or manages a condition, such as insomnia, diabetes or addiction."
canonical: https://www.getswoopr.com/stocks/industries/health-care/digital-therapeutics/
source: "Swoopr Investment: https://www.getswoopr.com"
---

# Digital Therapeutics Industry

## Direct Answer

Digital therapeutics companies deliver clinically tested software that treats or manages a condition, such as insomnia, diabetes or addiction, often with a prescription code. Revenue depends on payer coverage and clinician adoption, which have been slow to scale.

## Industry Overview

Digital Therapeutics sits within the health care sector. The first numbers to compare across companies here are prescriptions or activations, revenue per patient and coverage lives from payers. The outside forces that move them are listed under Primary Macro Drivers.

## Key Industry Metrics

- **Prescriptions or activations**: Number of times clinicians prescribe or patients start a software treatment. It is the earliest uptake signal, but a prescription that is not activated or continued does not generate revenue.
- **Revenue per patient**: Average income received for each patient treated, depending on payer rates. Low figures reflect limited reimbursement, so check whether insurers are paying the price or discounts are absorbing it.
- **Coverage lives from payers**: Number of insured people whose plans cover the product. Coverage is a precondition for scale, since patients seldom pay out of pocket; compare covered lives with actual prescriptions.
- **Cash burn and runway**: Rate of cash spent each period and the months it can fund before new financing. For companies with limited revenue, a short runway raises the chance of dilution or restructuring.
- **Clinical evidence and regulatory clearances**: Trial results and regulatory authorizations supporting the software as a medical product. Payers often require strong outcome evidence, so more evidence can widen coverage.

## Primary Macro Drivers

- **Payer reimbursement pathways**: Software can only scale when insurers pay for it, so a coverage pathway moves prescriptions and revenue per patient more than clinical results alone do.
- **Regulatory clearance of software as a medical device**: Regulators must clear a product as a medical device before it can be prescribed, so clearance timing sets launch dates and what claims can be made.
- **Employer and health plan programs**: Employers and health plans that pay for programs for their members create large contracts, which show up in covered lives and activations.
- **Clinician prescribing habits**: Doctors prescribe only what fits their workflow and what they trust, so habits determine how many codes are issued and filled.

## Major Risks

- **Limited reimbursement and slow uptake**: Without broad payment, few patients get access, so revenue per patient and activations stay low; watch covered lives and the number of paying plans.
- **Funding and cash burn**: Many companies spend more than they earn, so if funding is hard to raise they may cut programs or dilute holders; watch cash burn against runway.
- **Competition from free apps**: Free or low-cost apps compete for the same patients and can limit pricing; watch activation counts and revenue per patient.
- **Evidence thresholds for payers**: Payers ask for strong evidence before paying, so trials take time and money before revenue starts; watch published outcome data and payer coverage decisions.

## Industry Characteristics

| Characteristic | Profile |
| --- | --- |
| Cyclicality | Defensive |
| Capital Intensity | Low |
| Regulatory Intensity | High |
| Industry Maturity | Emerging |
| Geographic Importance | U.S. |

## Companies Associated with Digital Therapeutics

The SEC's Standard Industrial Classification has no code that describes digital therapeutics as a group, so there is no complete list of its filers. The companies below come from Swoopr's SEC dataset and have operations in or next to the industry. Each is classified by the SEC under its own main business.

| Company | SEC classification | Revenue | Growth | Net margin | Year |
| --- | --- | --- | --- | --- | --- |
| [Dexcom Inc](https://www.getswoopr.com/stocks/companies/dexcom/) | Surgical & Medical Instruments & Apparatus | $4.7 billion | 15.6% | 17.9% | FY 2025 |
| [Teladoc Health, Inc.](https://www.getswoopr.com/stocks/companies/teladoc-health-inc/) | Services-Offices & Clinics Of Doctors Of Medicine | $2.5 billion | -1.5% | -7.9% | FY 2025 |
| [Hims & Hers Health, Inc.](https://www.getswoopr.com/stocks/companies/hims-and-hers-health-inc/) | Services-Offices & Clinics Of Doctors Of Medicine | $2.3 billion | 59.0% | 5.5% | FY 2025 |

Source: each company's own annual report as filed with the SEC (XBRL data), figures in U.S. dollars. Listing here describes a business relationship to the industry, not a recommendation. To find more companies, use the [company directory](https://www.getswoopr.com/stocks/companies/) and the [health care hub](https://www.getswoopr.com/stocks/industries/health-care/).

## Where to Go Next

The Digital Therapeutics guide describes how the industry earns money, what to measure and what can go wrong. To see how it compares, read the neighbouring industries in the same sector, then apply the same checks to a specific company.

### More in Health Care

- [Health Care sector overview](https://www.getswoopr.com/stocks/industries/health-care/)
- [Drug Discovery Platforms](https://www.getswoopr.com/stocks/industries/health-care/drug-discovery-platforms/)
- [Dialysis Centers](https://www.getswoopr.com/stocks/industries/health-care/dialysis-centers/)
- [Electronic Health Records](https://www.getswoopr.com/stocks/industries/health-care/electronic-health-records/)
- [Diagnostics & Post-Acute Care](https://www.getswoopr.com/stocks/industries/health-care/diagnostics-and-post-acute-care/)
- [European Pharmaceuticals](https://www.getswoopr.com/stocks/industries/health-care/european-pharmaceuticals/)
- [Diagnostic Laboratories](https://www.getswoopr.com/stocks/industries/health-care/diagnostic-laboratories/)
- [Fertility Services](https://www.getswoopr.com/stocks/industries/health-care/fertility-services/)
- [Diagnostic Devices](https://www.getswoopr.com/stocks/industries/health-care/diagnostic-devices/)

### Put it to work

- [How to analyze a stock](https://www.getswoopr.com/stocks/how-to-analyze-a-stock/)
- [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/)
- [Company research](https://www.getswoopr.com/stocks/companies/)
- [All industries](https://www.getswoopr.com/stocks/industries/)

## Frequently Asked Questions

What are the main KPIs for the Digital Therapeutics industry?

Key performance indicators for the Digital Therapeutics industry include: Prescriptions or activations, Revenue per patient, Coverage lives from payers, Cash burn and runway, Clinical evidence and regulatory clearances. Which matter most depends on the company's model, so compare them across several companies rather than relying on one.

How cyclical is the Digital Therapeutics industry?

The Digital Therapeutics industry is generally defensive, meaning demand tends to remain relatively stable regardless of the economic cycle. Companies in this space can provide portfolio stability during recessions, though growth may lag in strong expansions.

What are the biggest risks in the Digital Therapeutics industry?

The primary risks for Digital Therapeutics companies include: Limited reimbursement and slow uptake, Funding and cash burn, Competition from free apps, Evidence thresholds for payers. Investors should assess each company's exposure to these factors and its track record of navigating them.

**[Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/)**

Swoopr's editorial team produces independent investment education content reviewed for accuracy and clarity. We do not provide personalized financial advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).
